Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

44.94 -0.05 (-0.11%)
Streaming Delayed Price Updated: 11:51 AM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! 
Via InvestorPlace
Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday. 
Via Benzinga
Topics Stocks
(EXAS) - Analyzing Exact Sciences's Short Interest
 
Via Benzinga
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
EXAS earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
EXAS Stock Earnings: Exact Sciences Misses EPS, Beats Revenue for Q1 2024
EXAS stock results show that Exact Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know
Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a quarterly... 
Via Benzinga
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
The company reported better-than-expected sales, but losses widened and missed forecasts. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Exact Sciences Announces First-Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
Stocks Falter As Fed Signals Need For Higher-For-Longer Rates; Uber Crashes, Energy Sector Loses Ground: What's Driving Wednesday's Market?
Wednesday witnessed a tempering of the bullish sentiment that had buoyed Wall Street in recent sessions, with major indices showing slight declines around midday trading in New York. 
Via Benzinga
Topics Economy
Wall Street Poised For Muted Open On Mixed Earnings, With More Fed Speeches In Store: Analyst Sees S&P 500 Crossing Late-March High
U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more speeches by Federal Reserve officials. 
Via Benzinga
Topics Economy Stocks
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
From Exact Sciences Corp.
Via Business Wire
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far. 
Via Benzinga
Topics Stocks
Exact Sciences to Participate in May Investor Conference
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
From Exact Sciences Corp.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Schedules First Quarter 2024 Earnings Call
From Exact Sciences Corp.
Via Business Wire
The 3 Best Cathie Wood Stocks to Buy in April 2024
Cathie Wood doesn't have a great overall record, but she sometimes makes great picks. Here are the three best Cathie Wood stocks to buy now. 
Via InvestorPlace
1 Beaten-Down Cathie Wood Stock to Buy and Hold
This company is innovating where it matters most, which could prove highly lucrative down the road. 
Via The Motley Fool
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
From Exact Sciences Corp.
Via Business Wire
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
The companies are working to detect colon cancer and precancerous markers in blood and/or stool. 
Via Investor's Business Daily
ChampionX, Montrose Environmental Group And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones falling around 400 points on Tuesday. 
Via Benzinga
Topics Stocks
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat... 
Via Benzinga
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
From Exact Sciences Corp.
Via Business Wire
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
From Exact Sciences Corp.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.